TriSalus Life Sciences, Inc.·3

Feb 11, 6:50 PM ET

Stansky Michael P 3

3 · TriSalus Life Sciences, Inc. · Filed Feb 11, 2026

Insider Transaction Report

Form 3
Period: 2026-02-04
Holdings
  • Common Stock

    [F1]
    543,232
  • Common Stock

    [F2]
    82,500
  • Warrant

    [F1]
    Exercise: $11.50From: 2023-08-10Exp: 2028-08-10Common Stock (827,500 underlying)
Footnotes (2)
  • [F1]The securities reported herein were acquired by the Reporting Person prior to the Reporting Person becoming a director of the issuer. The Reporting Person was appointed as a director of the Issuer effective February 4, 2026.
  • [F2]The securities reported herein are owned by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member.
Signature
/s/ Michael P. Stansky|2026-02-11

Documents

1 file
  • 3
    wk-form3_1770853801.xmlPrimary

    FORM 3